Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mélodie Malige"'
Autor:
Laurent Mosoni, Arno Germond, Cécile Coudy-Gandilhon, Mélodie Malige, Agnès Claustre, Coralie Delabrise, Mehdi Djelloul-Mazouz, Yoann Delorme, Julien Hermet, Pierre Fafournoux, Lydie Combaret, Cécile Polge, Anne-Catherine Maurin, Daniel Taillandier
Publikováno v:
ACS Omega, Vol 9, Iss 45, Pp 45610-45623 (2024)
Externí odkaz:
https://doaj.org/article/8ef06466bd9e4095b1b5bc745bf7547c
Autor:
Arnaud Briat, Claire Jacques, Mélodie Malige, Laure Sudre, Geoffroy Nourissat, Philippe Auzeloux, Hans Guehring, Florent Cachin, Francis Berenbaum, Elisabeth Miot-Noirault
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract With the emergence of disease modifying osteoarthritis drugs (DMOAD), imaging methods to quantitatively demonstrate their efficacy and to monitor osteoarthritis progression at the functional level are urgently needed. Our group showed that a
Externí odkaz:
https://doaj.org/article/46cfa10ea81e452cb5cdb16ba745afab
Autor:
Dulce Peris-Moreno, Mélodie Malige, Agnès Claustre, Andrea Armani, Cécile Coudy-Gandilhon, Christiane Deval, Daniel Béchet, Pierre Fafournoux, Marco Sandri, Lydie Combaret, Daniel Taillandier, Cécile Polge
Publikováno v:
Cells, Vol 10, Iss 8, p 1974 (2021)
The ubiquitin proteasome system (UPS) is the main player of skeletal muscle wasting, a common characteristic of many diseases (cancer, etc.) that negatively impacts treatment and life prognosis. Within the UPS, the E3 ligase MuRF1/TRIM63 targets for
Externí odkaz:
https://doaj.org/article/eafcf854ca3a4cd39cea670eff0920c1
Autor:
Polge, Dulce Peris-Moreno, Mélodie Malige, Agnès Claustre, Andrea Armani, Cécile Coudy-Gandilhon, Christiane Deval, Daniel Béchet, Pierre Fafournoux, Marco Sandri, Lydie Combaret, Daniel Taillandier, Cécile
Publikováno v:
Cells; Volume 10; Issue 8; Pages: 1974
The ubiquitin proteasome system (UPS) is the main player of skeletal muscle wasting, a common characteristic of many diseases (cancer, etc.) that negatively impacts treatment and life prognosis. Within the UPS, the E3 ligase MuRF1/TRIM63 targets for